2 months ago
MANE
AnalystsRoger SongRoger Song's Stock Forecasts
AnalystsRoger Song
Analyst Ranking
Top 16%
#872 out of 5511 analysts
Average Return
+17.35%
Win Rate
43%27 out of 63
Risk vs Reward
Poor
Good
Roger Song's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nektar TherapeuticsNKTR | +736.48% | $9.27 | $77.50 | 2025-04-11 - 2026-04-10 | Strong Buy |
Mbx Biosciences IncMBX | +365.99% | $14.72 | $68.57 | 2025-08-15 - 2026-08-14 | Strong Buy |
Oruka Therapeutics IncORKA | +249.51% | $26.38 | $92.20 | 2025-11-13 - 2026-09-15 | Strong Buy |
Atyr Pharma IncATYR | +212.57% | $1.75 | $5.47 | 2024-09-05 - 2025-09-04 | Strong Buy |
Kiniksa Pharmaceuticals International PLCKNSA | +161.57% | $30.37 | $79.44 | 2025-07-29 - 2026-07-28 | Strong Buy |
Roger Song Analyst Color
Get additional color on Roger Song's coverage of popular stocks
3 months ago
NRIX
5 months ago
KNSA
5 months ago
ALLO
6 months ago
CTMX
7 months ago
BIOA
7 months ago
KRYS
10 months ago
NKTR
3 years ago
VKTX
Roger Song's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Inovio Pharmaceuticals IncINO | 1 | Strong Buy | $3.00 | +158.62% | Upgrades | a month ago |
Veradermics IncMANE | 2 | Strong Buy | $182.00 | +75.19% | Maintains | 2 months ago |
Nurix Therapeutics IncNRIX | 2 | Strong Buy | $45.00 | +81.23% | Maintains | 3 months ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $11.00 | +222.58% | Initiates Coverage On | 4 months ago |
Kailera Therapeutics IncKLRA | 1 | Strong Buy | $48.00 | +256.88% | Initiates Coverage On | 4 months ago |
Kiniksa Pharmaceuticals International PLCKNSA | 4 | Strong Buy | $71.00 | -5.52% | Maintains | 5 months ago |
Allogene Therapeutics IncALLO | 1 | Strong Buy | $10.00 | +481.40% | Maintains | 5 months ago |
Replimune Group IncREPL | 3 | Hold | $2.00 | -84.65% | Downgrades | 5 months ago |
Cytomx Therapeutics IncCTMX | 4 | Strong Buy | $16.00 | +494.80% | Maintains | 6 months ago |
Bioage Labs IncBIOA | 3 | Strong Buy | $62.00 | +657.95% | Upgrades | 7 months ago |
Krystal Biotech IncKRYS | 2 | Strong Buy | $371.00 | +10.19% | Maintains | 7 months ago |
Protagonist Therapeutics IncPTGX | 1 | Strong Buy | $118.00 | -17.71% | Maintains | 7 months ago |
Corvus Pharmaceuticals IncCRVS | 2 | Strong Buy | $42.00 | +224.32% | Maintains | 8 months ago |
Nektar TherapeuticsNKTR | 11 | Strong Buy | $121.00 | +81.57% | Maintains | 10 months ago |
Oruka Therapeutics IncORKA | 1 | Strong Buy | $45.00 | -51.19% | Initiates Coverage On | 10 months ago |
Gyre Therapeutics IncGYRE | 1 | Strong Buy | $16.00 | +139.16% | Initiates Coverage On | a year ago |
Tourmaline Bio IncTRML | 3 | Hold | $47.50 | N/A | Downgrades | a year ago |
United Therapeutics CorpUTHR | 1 | Strong Buy | $564.00 | N/A | Maintains | a year ago |
Biomea Fusion IncBMEA | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | a year ago |
Atyr Pharma IncATYR | 2 | Strong Buy | $17.00 | N/A | Maintains | a year ago |
Mbx Biosciences IncMBX | 1 | Strong Buy | $36.00 | N/A | Assumes | a year ago |
Lava Therapeutics NvLVTX | 1 | Hold | $1.50 | N/A | Downgrades | a year ago |
Verve Therapeutics IncVERV | 1 | Hold | $11.00 | N/A | Downgrades | a year ago |
Curevac NvCVAC | 1 | Hold | $5.00 | N/A | Downgrades | a year ago |
Akebia Therapeutics IncAKBA | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | a year ago |
Sana Biotechnology IncSANA | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | 2 years ago |
Wave Life Sciences IncWVE | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 2 years ago |
Igm Biosciences IncIGMS | 2 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Kura Oncology IncKURA | 2 | Strong Buy | $28.00 | N/A | Maintains | 2 years ago |
Aclaris Therapeutics IncACRS | 1 | Strong Buy | $7.00 | N/A | Upgrades | 2 years ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | N/A | Initiates Coverage On | 2 years ago |
Novavax IncNVAX | 2 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Zenas Biopharma IncZBIO | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Vaxcyte IncPCVX | 1 | Strong Buy | $129.00 | N/A | Maintains | 2 years ago |
Nuvalent IncNUVL | 1 | Strong Buy | $97.00 | N/A | Initiates Coverage On | 2 years ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 3 years ago |
Kinnate Biopharma IncKNTE | 2 | Strong Buy | $2.00 | N/A | Maintains | 3 years ago |
Altimmune IncALT | 1 | Strong Buy | $35.00 | N/A | Maintains | 4 years ago |
Prelude Therapeutics IncPRLD | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 4 years ago |
Whitehawk Therapeutics IncWHWK | 1 | Strong Buy | $675.00 | N/A | Initiates Coverage On | 5 years ago |
Crescent Biopharma IncCBIO | 1 | Strong Buy | $4.00 | N/A | Upgrades | 5 years ago |
Atreca IncBCEL | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Molecular Templates IncMTEM | 1 | Strong Buy | $315.00 | N/A | Initiates Coverage On | 6 years ago |
Sutro Biopharma IncSTRO | 1 | Strong Buy | $210.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.